Novavax | NVAX - الأصول





الأصول تغيير تاريخ
Adma Biologics USD 684.21M 19.03M 2026-06
Agenus USD 172.69M 13.76M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Cassava Sciences USD 108.37M 9.99M 2026-03
Geron USD 519.01M 15.11M 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
MannKind USD 732.3M 12.1M 2026-06
Merck USD 129.8B 1.12B 2026-06
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Moderna USD 10.96B 527M 2026-06
Novartis USD 118.53B 7.58B 2026-03
Novavax USD 955.58M 87.59M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
TG Therapeutics USD 1.64B 110.79M 2026-06